Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP862636.RANXGdXFKt_RIzqTaTVbtyrf9PaT7ismHP-riQLG7DVjs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP862636.RANXGdXFKt_RIzqTaTVbtyrf9PaT7ismHP-riQLG7DVjs130_assertion type Assertion NP862636.RANXGdXFKt_RIzqTaTVbtyrf9PaT7ismHP-riQLG7DVjs130_head.
- NP862636.RANXGdXFKt_RIzqTaTVbtyrf9PaT7ismHP-riQLG7DVjs130_assertion description "[Increased RGS17 expression in some prostate and lung cancers has been demonstrated to support cancer progression, while reduced expression of RGS17 can lead to development of chemotherapeutic resistance in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862636.RANXGdXFKt_RIzqTaTVbtyrf9PaT7ismHP-riQLG7DVjs130_provenance.
- NP862636.RANXGdXFKt_RIzqTaTVbtyrf9PaT7ismHP-riQLG7DVjs130_assertion evidence source_evidence_literature NP862636.RANXGdXFKt_RIzqTaTVbtyrf9PaT7ismHP-riQLG7DVjs130_provenance.
- NP862636.RANXGdXFKt_RIzqTaTVbtyrf9PaT7ismHP-riQLG7DVjs130_assertion SIO_000772 23734683 NP862636.RANXGdXFKt_RIzqTaTVbtyrf9PaT7ismHP-riQLG7DVjs130_provenance.
- NP862636.RANXGdXFKt_RIzqTaTVbtyrf9PaT7ismHP-riQLG7DVjs130_assertion wasDerivedFrom befree-20140225 NP862636.RANXGdXFKt_RIzqTaTVbtyrf9PaT7ismHP-riQLG7DVjs130_provenance.
- NP862636.RANXGdXFKt_RIzqTaTVbtyrf9PaT7ismHP-riQLG7DVjs130_assertion wasGeneratedBy ECO_0000203 NP862636.RANXGdXFKt_RIzqTaTVbtyrf9PaT7ismHP-riQLG7DVjs130_provenance.